Lorazepam - Anxiety
You are here : Home > Formulary Search > Lorazepam - Anxiety
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
For short term use only
Do not offer a benzodiazepine for the treatment of any anxiety disorder in primary or secondary care except as a short-term measure (2-4 weeks) during crisis. Follow the advice in the BNF on the use of a benzodiazepine in this context.
Avoid in the elderly
Beware of MHRA advice on coprescribing of benzodiazepines and opioid and risk of death
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Lorazepam
Indication :
Anxiety
Group Name :
Keywords :
benzodiazepines, anxiolytics
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Committee Recommendations (1)
This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status
Other Indications
Below are listed other indications that Lorazepam is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Anxiety.